Current Portfolio
Artios Pharma
Next generation DNA Damage Response (DDR) target pipeline with the potential to transform cancer therapy.
Key Facts
- Sector
Life Sciences
- Country
United Kingdom
- Fund
LSP 6
- Entry
2018
Do You Want to Know More?
We are eager to explore how we can achieve great things together.